| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 03/02/2006 | CA2575721A1 Thymic stromal lymphopoietin promoter and uses therefor |
| 03/01/2006 | EP1630229A2 Melanoma antigens |
| 03/01/2006 | EP1629008A1 Tnf-like secreted protein |
| 03/01/2006 | EP1628996A2 Imageable animal model of sars infection |
| 03/01/2006 | EP1563084A4 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | EP1456375B1 Screening methods employing fish model assessment of vision |
| 03/01/2006 | EP1305636B1 Screening method |
| 03/01/2006 | EP1290139B1 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
| 03/01/2006 | EP1244433B1 Use of non-human SHIP2 knock-out mammals |
| 03/01/2006 | EP1141252B1 Human delta 5-desaturase gene and uses thereof |
| 03/01/2006 | EP0920498B1 Hamster ef-1alpha transcriptional regulatory dna |
| 03/01/2006 | CN1742088A Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | CN1740315A A transgenic mouse liver disease animal model producing process and application thereof |
| 03/01/2006 | CN1739347A Intermediate peashrub herb enzymolyzing feed and its prepn process and application |
| 03/01/2006 | CN1739346A First merogenesis inhibiting method for fertilized egg of lefteye flounder |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 02/28/2006 | US7005299 gene trap vector containing expression unit of internal ribosome binding site coupled to heterologous gene sequence (antibiotic resistance), for insertion/transformation within mouse embryonic stem cell; homologous recombination |
| 02/28/2006 | US7005297 Use of neuroactive compounds |
| 02/28/2006 | US7005296 contains transposon digested with restriction enzyme, green fluorescent protein, promoter region of polyubiquitin gene, nuclear localizing sequence of an SV40 virus, and chaperone proteins; for production of transgenic insects |
| 02/28/2006 | US7005275 Inducible alphaviral gene expression system |
| 02/28/2006 | US7004109 Aquaculture of marine worms |
| 02/23/2006 | WO2006019153A1 NONHUMAN ANIMAL WITH INHIBITED GdsmA GENE FUNCTION AND PROMOTED OR INHIBITIED CANCERATION-ASSOCIATED GENE FUNCTION |
| 02/23/2006 | WO2006018998A1 Method of constructing clone mammal |
| 02/23/2006 | WO2006018316A1 Methods for the production of improved live stocks and disease models for therapeutic research |
| 02/23/2006 | WO2005107447A3 Methods for the production of improved live stocks and disease models for therapeutic research |
| 02/23/2006 | WO2005030928A3 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 02/23/2006 | US20060041948 Transgenic mice containing chemokine receptor 9A gene disruptions |
| 02/23/2006 | US20060041947 Nessie nucleic acids, polypeptides and mutations, and methods of use thereof |
| 02/23/2006 | US20060041946 Nuclear transfer nuclei from histone hypomethylated donor cells |
| 02/23/2006 | US20060041945 Bovine with homozygous mutations of both alleles that lacks functional immunoglobulin M (IgM) heavy chain; reduced levels of endogenous IgM heavy chain and/or prion protein; use to alleviate risk or fear of bovine spongiform encephalopathy (mad cow disease) |
| 02/23/2006 | US20060041111 Dock 3 tumor suppressor gene |
| 02/23/2006 | US20060040384 Serum free cultivation of primate embryonic stem cells |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | CA2574098A1 Retinal dystrophin transgene and methods of use thereof |
| 02/22/2006 | EP1627915A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these |
| 02/22/2006 | EP1627887A2 Mouce trace amine associated receptors |
| 02/22/2006 | EP1627563A1 Means and methods for producing a stabilized cell of interest |
| 02/22/2006 | EP1626623A2 Method for cloning in the rat by nuclear transfer |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0656060B1 Androgen regulation with dna sequences of rat probasin gene |
| 02/22/2006 | CN2759172Y Partitioned cocooning frame used for silkworm |
| 02/22/2006 | CN1738900A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1736186A Method for breeding fly maggot with anti-tumor biological characteristic |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | CA2431859C Transgenic and cloned mammals |
| 02/16/2006 | WO2006017788A2 TRANSGENIC HFN4α MICE EXPRESSING THERAPEUTIC TARGET AF1 DOMAINS AND THEIR METHODS OF USE AS MODELS FOR METABOLIC DISORDERS |
| 02/16/2006 | WO2006017775A1 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/16/2006 | WO2006016808A2 Means and methods for producing a stabilized cell of interest |
| 02/16/2006 | WO2006016692A1 Knockout nonhuman animal |
| 02/16/2006 | WO2006016135A2 Enhanced aquaculture feeds |
| 02/16/2006 | WO2006015996A1 Animal model of neurodegenerative diseases, method of obtaining same and uses thereof |
| 02/16/2006 | WO2006002902A3 Methods for the production of improved live stocks and disease models for therapeutic research |
| 02/16/2006 | WO2005077095A3 Ccn1 transgenic animals |
| 02/16/2006 | WO2005037191A3 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 02/16/2006 | WO2003066883A3 A transcription amplification system for molecular imaging |
| 02/16/2006 | WO2003050293A3 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
| 02/16/2006 | US20060037094 Secreted protein associated with depression, compositions and methods of use thereof |
| 02/16/2006 | US20060037093 Transgenic transchromosomal rodents for making human antibodies |
| 02/16/2006 | US20060037092 Universal stem cells |
| 02/16/2006 | US20060037091 Method for producing hypertrophic scarring animal model for identification of agents for prevention and treatment of human hypertrophic scarring |
| 02/16/2006 | US20060037090 include muscle mass and/or fat deposition lean meat, lean back fat, sow prolificacy and/or sow longevity; insulin-like growth factor 2 (IGF2); drug screening |
| 02/16/2006 | US20060037089 Non-human transgenic animal models and cells; dermatitis, psoriasis, airway allergy, asthma, AIDS, an autoimmune disorder or graft rejection |
| 02/16/2006 | US20060037088 Gene expression levels as predictors of chemoradiation response of cancer |
| 02/16/2006 | US20060037087 Recombinant vectors for treating E coli infections more specifically those that result in post weaning diarrhea or scours |
| 02/16/2006 | US20060037086 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals |
| 02/16/2006 | US20060037085 Animal model for fetal alcohol syndrome and methods of treatment |
| 02/16/2006 | US20060035373 Stem cell libraries |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035330 Non aggregating fluorescent proteins and methods for using the same |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035303 JNK3 modulators and methods of use |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | CA2576415A1 Knockout nonhuman animal |
| 02/16/2006 | CA2576151A1 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/16/2006 | CA2576018A1 Animal model of neurodegenerative diseases, method of obtaining same and uses thereof |
| 02/16/2006 | CA2575989A1 Means and methods for producing a stabilized cell of interest |
| 02/16/2006 | CA2573339A1 Immune-compromised transgenic mice expressing human hepatocyte growth factor (hhgf) |
| 02/15/2006 | EP1626056A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity |
| 02/15/2006 | EP1625395A1 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/15/2006 | EP1625223A2 Chemoenzymatic methods for the synthesis of statins and statin intermediates |
| 02/15/2006 | EP1624749A1 Dilution of genetic traits |
| 02/15/2006 | EP1624748A2 A transgenic animal model for cancer and stem cells |
| 02/15/2006 | EP1328652B1 Non-human transgenic animal expressing ca-ahr |
| 02/15/2006 | EP1118664B1 Method for producing choroid plexus immortalized cell lines |
| 02/15/2006 | EP1065269B1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 02/15/2006 | CN1735338A Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 02/15/2006 | CN1735337A Microbial feedstock for filter feeding aquatic organisms |
| 02/15/2006 | CN1732770A Method for improving variety of hard clam |
| 02/15/2006 | CN1241646C Improvement in or relating to endometrial function |
| 02/14/2006 | US6998514 Murine expression of a human IgA lambda locus |
| 02/14/2006 | US6998513 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use |
| 02/14/2006 | US6998473 isolated polynucleotide molecules which encode the isoforms ; methods of screening compounds for vitamin D receptor (VDR) agonists and/or antagonists |
| 02/14/2006 | US6998472 Obesity gene |
| 02/14/2006 | US6998266 Active retinoic acid-free culture medium for avian totipotent embryonic stem cells |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | CA2384170C Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same |
| 02/09/2006 | WO2006014985A2 Genetic immunization of transgenic animals with non-eukaryotic expression systems |